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Systematic Assessment of Seven 
Solvent and Solid-Phase Extraction 
Methods for Metabolomics Analysis 
of Human Plasma by LC-MS
Dmitri G. Sitnikov1,2, Cian S. Monnin1 & Dajana Vuckovic1,2
The comparison of extraction methods for global metabolomics is usually executed in biofluids only 
and focuses on metabolite coverage and method repeatability. This limits our detailed understanding 
of extraction parameters such as recovery and matrix effects and prevents side-by-side comparison of 
different sample preparation strategies. To address this gap in knowledge, seven solvent-based and 
solid-phase extraction methods were systematically evaluated using standard analytes spiked into both 
buffer and human plasma. We compared recovery, coverage, repeatability, matrix effects, selectivity 
and orthogonality of all methods tested for non-lipid metabolome in combination with reversed-phased 
and mixed-mode liquid chromatography mass spectrometry analysis (LC-MS). Our results confirmed 
wide selectivity and excellent precision of solvent precipitations, but revealed their high susceptibility 
to matrix effects. The use of all seven methods showed high overlap and redundancy which resulted in 
metabolite coverage increases of 34–80% depending on LC-MS method employed as compared to the 
best single extraction protocol (methanol/ethanol precipitation) despite 7x increase in MS analysis time 
and sample consumption. The most orthogonal methods to methanol-based precipitation were ion-
exchange solid-phase extraction and liquid-liquid extraction using methyl-tertbutyl ether. Our results 
help facilitate rational design and selection of sample preparation methods and internal standards for 
global metabolomics.
The objective of global metabolomics is to analyze all small-molecular-weight species (≤ 1,500 Da) in a biological 
sample1. LC-MS is currently the method of choice for global metabolomics studies because it provides the highest 
metabolite coverage using a single analytical technique2. Typically, several hundred to thousand(s) metabolites can 
be detected in a single analysis3. The size of human metabolome is currently unknown, but is projected to exceed 
the conservative estimate of 4229 endogenous metabolites in concentrations spanning 11 orders of magnitude4. 
The most recent estimates predict 8500 endogenous metabolites5, and up to 40000 additional exogenous metabo-
lites, such as drugs, additives and toxins that may be present in human samples6. Considering the typical coverage 
of untargeted metabolomics analysis, it is clear that metabolome complexity is overwhelming the capacity of 
modern metabolomics methods. Therefore, new strategies to increase metabolome coverage are required.
The most widely used protocol for global metabolomics of plasma is solvent precipitation using cold methanol 
or methanol/ethanol (1/1, v/v) with a plasma-to-solvent ratio of 1 to 3 or 47–10. Cold solvent is added to minimize 
the extent of enzymatic conversion of metabolites and to precipitate the proteins. The removal of proteins 
from plasma also prevents protein build-up on LC column which improves LC column lifetime and significantly 
increases the number of detected metabolites through disruption of protein binding and minimizing number 
of signals originating from proteins11. Methanol and methanol/ethanol are the solvents of choice due to high 
metabolite coverage as shown by several studies8,9,11. However, the wide selectivity of such solvent-based pre-
cipitations results in highly complex samples which precludes the detection of lower abundance metabolites. 
Liquid-liquid extraction (LLE) using methyl-tertbutyl ether (MTBE) has become a popular alternative in recent 
years for its ability to provide good coverage of both polar and lipid metabolomes and compatibility with robotic 
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systems13,14. In contrast, solid-phase extraction (SPE) methods are often avoided in global metabolomics of 
plasma due to their increased selectivity comparative to methanol-based extraction methods. SPE methods, thus, 
tend to decrease overall metabolite coverage11 but may improve data quality through improved repeatability11,15  
and reduced matrix effects12,16. For instance, optimized HybridSPE™ successfully removed phospholipids in order 
to lower matrix effects while maintaining acceptable recoveries and repeatability11. In order to increase metabo-
lome coverage beyond what can be achieved with methanol-based precipitations, multiple orthogonal extraction 
methods can be combined in a sequential manner as successfully shown in lipidomics where 2-fold improve-
ment in coverage was achieved using different SPE fractionation approaches7,17. However, no similar sequential 
extraction approaches exist to date for non-lipid metabolome. To systematically design such sequential extraction 
protocol(s), it is necessary to directly compare coverage of various solvent precipitation, LLE and SPE methods. 
However, only a limited number of studies compared solvent precipitation methods to SPE and LLE to date7,11,12. 
Based on these published evaluations of extraction methods in real samples, a few limitations should be high-
lighted. None of these studies examine the orthogonality of SPE and MTBE methods to methanol-based methods 
in side-by-side fashion and comparison across the studies is not possible due to the different instrumentation and 
data processing strategies used. Most of these studies focus on metabolome coverage and extraction repeatability 
only, and no simultaneous evaluation of matrix effects and recovery in biological matrix has been performed 
to date. Recovery studies are crucial in order to design sequential extraction methods that are fully orthogonal 
and minimize spliting of the signal between multiple fractions. In addition, semi-quantitative comparisons of 
metabolite signal intensities between extraction methods can be misleading because variations in analyte sig-
nals due to matrix effects are not properly taken into account using the addition of stable isotope labeled (SIL) 
analytes18,19, fully isotopically-labeled complex matrices, or standard addition calibration. The latter approach 
was successfully employed to monitor and compare absolute recovery of sequential extraction by hybrid and 
mixed-mode SPE in untargeted metabolomics20. The underappreciated advantages of standard addition method 
become obvious when comparing different extraction methods. It is well-established that the slopes of calibration 
curves for biofluids originating from multiple populations can show significant differences21. Similarly, different 
matrix effects are expected in samples originating from extraction methods with different selectivity. In such 
cases, signal intensity changes may be driven by matrices alone leading to erroneous conclusions regarding the 
extraction performance. Although matrix effects are extensively studied in targeted bioanalysis, this issue has not 
been addressed in global metabolomics of biofluids except in one study where post-column infusion experiment 
was performed to identify region of significant ion suppression16. However, anecdotal evidence across multiple 
comparison studies shows potentially significant matrix effects with huge differences in signal intensity observed 
when using different extraction methods15,20,22. Therefore, the quantification of absolute recovery and matrix 
effects using a systematic set of standard analytes when evaluating multiple extraction methods is missing from 
comparisons to date, leaving a critical gap in our knowledge.
Following an extraction, the most frequently used LC separation in global metabolomics is the paral-
lel use of C18 reversed-phase (RP) chromatography and hydrophilic interaction chromatography (HILIC) to 
achieve good coverage of non-polar and polar metabolome respectively23,24. More recently, mixed-mode chro-
matographic materials combining RP and ion-exchange mechanisms in low-bleed MS-compatible stationary 
phases provide improved retention of a broad spectrum of metabolites25,26. The major objective of this study 
was to perform the first side-by-side comparison of three conventional solvent precipitation methods to test 
the effect of small changes in solvent polarity (methanol, methanol-ethanol, and methanol-MTBE), one LLE 
(MTBE) method and three post-deproteinization SPE methods (C18, mixed cation-anion exchange (IEX) and 
divinylbenzene-pyrrolidone (PEP2)) for LC-MS metabolomics of human plasma. Absolute recovery and matrix 
effects for standard analytes were evaluated for all seven extraction methods using standard addition method. 
The repeatability and selectivity/orthogonality of extraction methods were compared using both targeted metab-
olites and on global basis in combination with RP and mixed-mode IEX/RP (Scherzo) LC-MS. These data pave 
the way for the rational selection of the best and most complementary extraction methods of the human plasma 
metabolome and clearly show the effect of using multiple sample preparation methods in a given study design on 
metabolome coverage.
Methods
Solvents and reagents. LC-MS grade solvents/mobile phase additives and analyte standards were pur-
chased from Sigma-Aldrich (Oakville, ON, Canada) unless stated otherwise. ACTH (1–39) was obtained from 
Anaspec (Fremont, CA, USA). Norepinephrine (d6), cholic acid (d4), epinephrine (d3), dopamine (d4), mela-
tonin (d4), 4-aminobutanoic acid (d6) and phenylalanine (d5) were obtained from CDN Isotopes (Point-Claire, 
QC, Canada), while 13C6- thyroxine was purchased from Toronto Research Chemicals (Toronto, ON, Canada). 
MTBE was bought from Fisher Scientific (Toronto, ON, Canada), while all phospholipids were obtained from 
Avanti Polar Lipids (Alabaster, Alabama, USA). Kynurenine and D-erythro-sphingosine (further mentioned as 
sphingosine for brevity) were purchased from Cayman Chemicals (Ann Arbor, MI, USA). Solid stationary phases 
(PEP2, ODS-C18 and divinylbenzene conjugated with sulfonic acid and quaternary amine moieties (IEX)) were 
obtained from Agela Technologies (Wilmington, DE, USA). Citrated pooled human plasma was obtained from 
Bioreclamation (Baltimore, MD, USA) and was collected in accordance with the company’s code of ethics. All 
reagents were of analytical or higher grade.
Standard analyte mix. The chemical diversity of metabolome is enormous both in terms of polarity and 
charge27,28. Using predicted octanol/water partition values, metabolites in human plasma cover a polarity range 
from -5 (polyamines, amino acids) to 10 (fatty acids) to 35 (triacylglycerides)27. For the charge state, metabo-
lites can be separated into acidic, basic, neutral and zwitterion classes. For instance, the study analyzing charge 
properties of 2553 non-lipid human metabolites from Human Metabolome Database, found that approximately 
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22% of metabolites are neutral, while 46.5 and 18.2% contain acidic carboxylic and phosphate groups, respec-
tively. Basic aliphatic amines and aromatic heterocyclic nitrogen groups were found in 16 and 24.5% of non-lipid 
metabolites, while 13.8% of compounds were zwitterions29. The focus of current work is non-lipid metabolome, 
so standard metabolite selection was confined to metabolites with high to intermediate polarity typically found in 
blood plasma. A few lipids were also included in the mix to help in the assessment of matrix effects and method 
selectivity towards lipids, but systematic evaluation of extraction performance for lipids was beyond the scope of 
this study. Therefore, we evaluated extraction methods using standards with limited but systematic set of chemical 
properties that (i) resembled class composition of a target samples and included acids, bases, neutrals, zwitterions, 
lipids and small peptides, (ii) were systematic and scalable in terms of chemical properties (Log P range of − 3.9 
to 11.5, MW range of 105 to 900 Da), and (iii) amenable to the RP and mixed-mode LC-MS analytical methods 
employed in the study. All individual stock solutions were prepared in appropriate solvents as summarized in 
Supplementary Table 1, divided into aliquots and stored at below − 70 °C, while working standards were prepared 
at appropriate concentrations prior to analysis. Standard mix was prepared at 5 μ g/mL from appropriate stock 
solutions using 20% methanol unless otherwise specified.
Extraction of analyte standard from buffer. The standard mix was prepared at 5 μ g/mL of each com-
pound in 25 mM ammonium acetate, pH 6.5 buffer. This high concentration was required to avoid non-specific 
adsorptive losses. Buffer composition was selected to obtain suitable pH and ionic strength for IEX stationary 
phases in order to achieve maximum recovery of analytes, while ensuring MS compatibility. The standard mix 
was extracted in six replicates by solvent-precipitation (methanol/ethanol (1/1, v/v), methanol, methanol/MTBE 
(1/1, v/v), liquid-liquid extraction (MTBE) and solid-phase extraction (PEP2, C18, IEX). In solvent precipita-
tions and LLE, 100 μ L of standard mix was extracted with 400 μ L of ice-cold solvent, vortexed for 30 min and 
centrifuged for 15 min at 15000 × g. All steps were executed at 4 °C. After centrifugation, 350 μ L of the upper 
layer was dried and stored at below − 70 °C until analysis. For SPE, 100 μ L of standard mix was loaded on a 3 mL 
SPE cartridge containing 100 mg (C18, IEX) or 60 mg (PEP2) sorbent. The cartridges were washed with 1 mL of 
sample buffer and eluted into glass tubes with 1.5 mL of elution solvent specific for every sorbent: C18 with 0.1% 
formic acid in 100% acetonitrile, PEP2 with 150 mM ammonium acetate, pH 6.8 in 94% methanol and IEX with 
400 mM ammonium acetate pH 6.8 in 42% methanol. Eluted samples were evaporated to dryness under vacuum, 
and stored at below − 70 °C. Before analysis, all samples were reconstituted in 10 μ L of 20% methanol containing 
2.5 mM ammonium acetate (pH 6.5), sonicated at ambient temperature for 5 min, vortexed for 10 min, diluted 
with 90 μ L of 2.5 mM ammonium acetate, pH 6.5, sonicated and vortexed for 5 and 10 min and centrifuged at 
15000 × g for 30 s.
Extraction of plasma samples spiked with standard analytes. Solvent precipitations and LLE were 
carried out as described above using (i) the sample buffer (composed of 2% acetonitrile in 2.5 mM ammonium 
acetate pH 6.5) to obtain a blank extract for each method, (ii) plasma samples spiked with standard analytes to 
yield approximately 800 ng/ml before extraction and 100 ng/mL at LC-MS step in six replicates and (iii) unspiked 
plasma samples in 12 replicates to be pooled on per-method basis and used to build calibration curves for each 
method. Prior to SPE extraction, replicates of plasma and sample buffer were precipitated using methanol as 
described above, evaporated to dryness, reconstituted in the sample buffer, pooled as appropriate, and divided 
into replicates equivalent to 100 μ L of plasma. Six of these replicates were spiked with the standard analytes at 
800 ng/mL per each of three SPE methods. All samples were extracted by three SPE sorbents in parallel following 
the protocols described above to generate the sample sets similar to the one prepared for precipitation and LLE, 
i.e. blank extracts (i), spiked plasma extracts (ii), and unspiked plasma extracts (iii). All samples were dried under 
vacuum and stored at below − 70 °C.
Preparation of plasma extracts for LC-MS analysis. All plasma extracts were reconstituted in 30 μ L of 
20% methanol as described for standard analytes and further dissolved in 270 μ L of 2.5 mM ammonium acetate. 
Standard addition calibration curves were prepared for each extraction method by adding 30 μ L of the sample 
buffer or the mix of standard analytes to yield matrix calibration curve with 0 or 62.5, 125, 250 and 500 ng/mL, 
respectively. For the assessment of matrix effect, an external standard calibration curve in 2.5 mM ammonium 
acetate pH 6.5, 2% acetonitrile was also prepared in the same concentration range.
LC-MS analysis. All extracts (10 μ L injection volume) were analyzed on 1290 UPLC chromatograph (Agilent 
Technologies, Santa Clara, CA) using 3.0 μ m, mixed-mode Scherzo SM-C18, 2 × 150 mm column (Imtakt, 
Portland, OR) and 1.8 μ m Zorbax Eclipse octadecyl 2 × 200 mm column coupled to Agilent 6550 iFunnel Q-TOF 
mass spectrometer in positive and negative ESI in the mass range 100–1000 m/z. Additional details including 
LC-MS settings are provided in SI.
Data analysis. TOF Quant software (version B.07.00 SP1, Agilent) was used for the determination of abso-
lute recovery of standard metabolites from buffer and plasma. Raw data was extracted at 15 ppm mass accuracy, 
aligned within ± 0.15 min retention time, integrated and corresponding adducts were summarized. Protonated 
and deprotonated ions were used for all other analytes in positive and negative ESI, respectively except for mela-
tonin in positive ESI where sodiated adduct was also found. Quantitation was executed using external calibration 
curves in buffer and standard addition calibration in plasma. The recoveries of each analyte for each extraction 
method were hierarchically clustered using the Euclidian distance method with CIMminer online analysis at 
http://discover.nci.nih.gov/cimminer/oneMatrix.do30. The recoveries of analytes below 5 and above 80% were 
assigned to 0 and 100%, respectively for correct visualization. Matrix effect was calculated by dividing the peak 
area of an analyte in matrix calibration standard spiked post-extraction by the area in the calibration standard 
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prepared in the sample buffer at the same analyte concentration and converting to percentage. The subtraction of 
endogenous signals was performed using signal obtained in unspiked plasma extracts. The final results reported 
for matrix effect represent the mean value obtained across four different concentrations tested for each analyte. 
Pooled QC samples for all target analytes in all analytical batches showed RSD ≤ 25%. QC data showed no evi-
dence of analyte degradation in extracted plasma samples except possibly for histamine and sphingosine both 
of which showed systematic 20–30% decrease of signal intensity throughout the long analytical batches. For 
the global evaluation of the extraction methods, peak picking, deconvolution, alignment and integration were 
executed on Profinder (Agilent) with the following parameters: ion mass threshold of ± 15 ppm, relative height 
of MS + 1/MS isotope abundance 15%, RT threshold ± 0.15 min, minimum peak height 200 and 2000 counts 
for M + 1 and M peaks, respectively. The selectivity and repeatability analyses were carried out on Mass Profiler 
Professional (MPP, Agilent) with integration and binning parameters similar to Profinder, after removal of low 
quality metabolite signals that (i) were not at least 5x higher than the signal in blank and (ii) that were not found 
in at least 5 out of 6 replicates of a given extraction method. The data were manually verified and found to include 
2–3% duplicate entries (a feature split between multiple entries by the peak picking algorithm). Therefore, the 
accuracy of putative metabolite coverage is ± 3%. The orthogonality of extraction methods in global metabolom-
ics approach was evaluated in a pairwise manner using the above high-quality data. Number of matched features 
for all possible paired combinations were used for hierarchical clustering using CIMiner online tool.
Results and Discussion
Seven different extraction methods are compared based on the absolute recovery of standard analytes from buffer 
and human plasma, repeatability, selectivity and matrix effects in parallel with global LC-MS based metabolom-
ics analysis. The overall experimental design is shown in Supplementary Figure 1. To the best of our knowledge, 
this is the first side-by-side comparison of the quality of sample preparation from blood plasma by conventional 
solvent precipitations (methanol-ethanol, methanol, methanol-MTBE), LLE (MTBE) and SPE (C18, IEX, PEP2) 
methods in a single study.
Targeted Analysis
Recovery, repeatability and selectivity of metabolite extraction from buffer. Analyte recovery 
is summarized in Fig. 1a and Supplementary Table 2. The analytes are listed by increasing logP values retrieved 
from Chemspider database predicted using ACD Laboratories algorithm. The extraction methods are arranged 
according to the results of hierarchical analysis. As expected, methanol, methanol/ethanol and methanol/MTBE 
extractions clustered closely together and provided the broadest coverage and the highest recovery across the 
wide range of metabolite classes tested. IEX provided high recovery only for polar charged metabolites, while 
MTBE provided high recovery for hydrophobic neutral metabolites. Among SPE methods, PEP2 provided 
broader metabolite coverage than C18 (Table 1), due to its ability to retain some of the polar metabolites. The 
highest selectivity in buffer was demonstrated by IEX, followed by C18 and MTBE. Moreover, IEX and C18/
MTBE methods demonstrated little overlap, which can be exploited in sequential sample preparations for global 
and targeted metabolomics. None of the tested analytes exhibited ≥ 50% recovery in all of the extraction methods 
(Supplementary Table 2). Supplementary Table 4 summarizes the main performance characteristics of all extrac-
tions methods tested. The recovery of ≥ 80% is considered exhaustive and quantitative bioanalytical methods per-
mit method precision of up to ≤ 20% RSD at lower limit of quantitation. However, very few metabolites can meet 
these most stringent criteria for any of the tested methods as shown in Supplementary Table 4. Global metabolo-
mics methods are considered semi-quantitative, so applying more relaxed criteria of ≥ 50% recovery and ≤ 30% 
RSD is a reasonable compromise between method coverage and method performance. Using this criteria, meth-
anol-based precipitations can provide acceptable performance for 17 out of 22 metabolites. Overall, metabolite 
recovery correlated to the predicted LogP values and the expected selectivity of the extraction methods. Neutral 
metabolites such as melatonin demonstrated the best quantitative (≥ 80%) recoveries amongst all standard 
metabolites. The best repeatability was demonstrated by methanol-based precipitations (Supplementary Table 4). 
SPE and LLE methods demonstrated lower repeatability then methanol blends with the poorest performance by 
MTBE and C18 SPE (Supplementary Table 4). This poor repeatability of MTBE is attributed to irreproducible 
partitioning of some metabolites between organic and aqueous phases, and was most pronounced for pantothenic 
acid, thyroxine and phenylalanine.
Recovery, repeatability and selectivity of metabolite extraction from plasma. The high recovery 
(≥ 80%) was demonstrated by thyrotropin releasing hormone and melatonin in 6 out of 7 methods tested (Fig. 1b, 
Supplementary Table 3). Ionic compounds such as histamine, tyrosine and kynurenine with low molecular weight 
and LogP values demonstrated quantitative recovery in only 1 out of 7 methods. In addition, better recovery of 
triiodothyronine, thyroxine and the large peptide neurotensin (in contrast to tripeptide thyrotropin releasing hor-
mone) was observed on RP SPE comparative to solvent based extractions (Supplementary Table 3A). The recov-
ery of some analytes from plasma changed drastically in plasma versus buffer. The recovery of neutral compounds 
(cortisol, cortisone) by MTBE, PEP2 and C18 was decreased in plasma but the recovery in methanol-based sol-
vents increased (Supplementary Tables 2A and 3A). This clearly shows the importance of performing recovery 
studies in biofluid matrix. The extraction repeatability (Supplementary Table 3B) showed similar trends to what 
was seen in buffer with methanol-based methods outperforming both SPE and LLE methods. However, SPE 
and LLE methods showed significant deterioration of method precision. For instance, MTBE method provided 
acceptable precision (≤ 30% RSD) for only melatonin, cortisol and triiodothyronine. Hierarchical clustering 
results shown in Fig. 1b confirm wide metabolite coverage of gold standard methanol-based solvent precipitation 
methods with high recovery across metabolite classes. The results also show the selectivity of MTBE is narrowed 
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to uncharged species with LogP ≥ 1.4 and confirm orthogonal selectivity of IEX and MTBE methods previously 
observed for buffer. This can be used for the removal of hydrophobic compounds in sequential sample prepara-
tions. The effect of adding a second MTBE extraction step was also investigated to examine if this will further 
improve the metabolite recovery. The results of this experiment are shown in Supplementary Table 5. Only the 
recovery of folic acid and adenine increased when the second extraction step is included. For the remaining 
metabolites, no significant changes within experimental error where observed as expected theoretically due to 
high polarity of many of the metabolites within standard mix. Finally, methanol-based methods provide the most 
comprehensive and reproducible extraction of standard analytes from plasma (Fig. 1) as indicated by much lower 
mean RSD values than observed for other extractions (Supplementary Table 4). The more selective methods of 
SPE and LLE show good performance only for a narrow range of metabolites that are best suited to each extrac-
tion method depending on their polarity and charge characteristics. In both Supplementary Tables 2 and 3, some 
metabolites show recoveries above 120% in some of SPE methods. This result was surprising, considering the 
similar matrix composition of standard addition calibration and unknown samples, so it was investigated further. 
The first possibility considered was different adduct formation in buffer versus plasma. No such differences were 
found, so this was eliminated as contributing factor. Melatonin and melatonin d4 both had similar high recoveries 
in PEP2 and C18 SPE, which pointed to the fact this result may be due to co-suppression of spiked metabo-
lites. The only compositional difference between calibration standards and samples used to evaluate recovery is 
the number of spiked metabolites present. Calibration standards were spiked after extraction and will therefore 
Figure 1. Hierarchical analyses and heat maps show the recovery of standard analytes from buffer (a) and 
human plasma (b). All extraction methods were hierarchically clustered using Euclidian distance method. 
The intensity of each cell represents range of recovery of an analyte relative to the initial amount spiked prior 
extraction. Recoveries below 5 and above 80% were assigned to 0 and 100%, for visualization purposes. The 
order of analytes corresponds to the increase in octanol-water partition coefficients, except for angiotensin II 
which did not have predicted value.
Evaluation of matrix 
effects








MTBE Methanol MTBE IEX PEP2 C18
Suppressed (+ ESI) 6 6 6 4 7 9 5 4 4 4 4 4 7 5
Enhanced (+ ESI) 5 5 5 4 2 4 2 11 11 11 7 7 3 2
Total affected (+ ESI) 11 11 11 8 9 13 7 15 15 15 11 11 10 7
Total unaffected (+ ESI) 6 6 6 12 7 4 10 2 2 1 8 4 7 10
Suppressed (−ESI) 3 3 5 0 1 1 1 7 4 9 1 10 5 3
Enhanced (− ESI) 2 2 2 2 4 7 8 4 3 2 5 1 4 2
Total affected (− ESI) 5 5 7 2 5 8 9 11 7 11 6 11 9 5
Total unaffected (− ESI) 5 5 3 10 9 6 5 2 6 2 8 1 4 9
Table 1.  Summary of total number of standard analytes which experienced matrix effect (suppression 
or enhancement) across different extraction methods in combination with either RP or mixed-mode 
LC-MS analysis. Analytes (n = 24, including SIL analogues for some of the metabolites) were counted if they 
were detected in buffer and at least one of the post-extraction spiked calibration standards. For metabolites 
detected at all concentration levels the mean matrix effect obtained across all concentration levels is reported. 
A metabolite was considered to be enhanced if its matrix effect ratio exceeded 120% or suppressed if it was less 
than 80%. The species that were not detected in either matrix were not counted, because matrix effect could not 
be properly determined for such cases. Supplementary Table 7 shows full results for matrix effect evaluation.
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contain all metabolites of the standard mix, whereas the recovery samples were spiked before extraction and will 
remove or incompletely extract some of the metabolites from standard mix depending on the extraction method 
selectivity. This was further verified by re-analyzing the same extracts on longer chromatographic method (60 min 
analysis time), and proper quantitative recovery (80–120%) was obtained in all instances. These results clearly 
show that global metabolomics methods are extremely susceptible to matrix effects and that semi-quantitative 
performance of these methods can be affected by minor differences in matrix composition.
Extraction preferences of standard analytes. Two groups of analytes emerged based on our recovery 
studies in buffer and plasma (Fig. 1). Analytes with LogP below 0.4 (above tyrosine) show poor recovery in MTBE 
and good recovery in methods suitable for extraction of polar species such as PEP2 and methanol-based solvent 
precipitations (Group I). The second group consists of less polar analytes (LogP ≥ 0.4) which demonstrate good 
recovery in MTBE, PEP2 and C18 (Group II). Interestingly, Group II analytes had recoveries ≥ 50% in most 
solvent and SPE methods in contrast to their recoveries from buffer. This difference in recovery is attributed 
to adsorptive losses in buffer. In the experiments with buffer we tried to minimize these losses by using high 
metabolite concentrations, but clearly adsorptive losses were still considerable especially for metabolites such as 
thyroxine, cortisone and cortisol. In conclusion, side-by-side systematic comparison of the absolute recovery of 
extraction methods was possible using standard addition calibration and showed clearly the critical importance 
of recovery determination in biofluids.
Matrix effects. Matrix effects were evaluated using the post-extraction spike method at up to four differ-
ent concentration levels. This evaluation was performed using both RP and mixed-mode LC-MS methods in 
positive and negative ESI. Ion suppression was observed for metabolites with lower LogP values (melatonin, 
4-aminobutanoic acid, adenine and homovanillic acid) in methanol-based extractions in RP. Neutral analytes 
of intermediate polarity with LogP of 1.2 (cortisol and cortisone) were not affected in any extraction method, 
while signals from more hydrophobic metabolites (LogP ≥ 1.4, triiodothyronine and thyroxine) were enhanced 
in all solvent-based extracts, supressed in IEX and PEP2 and remained unaffected in C18 SPE. The suppres-
sion in solvent-based extractions in –ESI RP (Supplementary Figure 2, Supplementary Tables 6 and 7) affected 
wider range of analytes than in + ESI and extends toward neutral mid-hydrophobic analytes (cortisol and cor-
tisone), while organic acids (folic, pantothenic, homovanillic and cholic) remained unaffected. The suppression 
of polar analytes in RP analysis in both positive and negative ESI is not surprising and could be explained by the 
co-elution of large number of un-retained metabolites. However, mixed-mode LC-MS analysis which is capa-
ble of chromatographically separating the majority of these charged species also shows very significant prob-
lems with ionization suppression and/or enhancement depending on the analyte and extraction method tested. 
Previous studies have also shown that HILIC methods are also highly susceptible to matrix effects even when 
using microextraction format22. Matrix effect could be partially decreased via improved resolution at LC-MS 
step by the decrease of stationary phase particle size (< 2 μ m) or drastic increase of column length and chro-
matography time to limits which may be impractical in real study31. Therefore, there is no simple solution to 
Figure 2. Overview of experimental design to compare seven extraction methods for untargeted 
metabolomics analysis of human plasma. 
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implement to address this major problem. Finally, methanol-based extracts demonstrated higher number of ana-
lytes affected by matrix effect. In contrast, the more selective MTBE and C18 SPE methods showed matrix effects 
for fewer metabolites and less pronounced extent of suppression/enhancement if matrix effects were present 
(Table 1, Supplementary Figure 2). The higher suppression matrix effect observed for methanol blends is most 
likely caused by higher matrix complexity as compared to MTBE and C18 SPE methods which are more selective 
as shown by our recovery experiments. Overall, the results of this comparison show that matrix effects pose a 
significant challenge in all extraction protocols and can have significant impact on biomarker discovery efforts. 
Additional ways to reduce and evaluate matrix effects during such studies should be explored and implemented. 
Table 1 also shows that the analyses performed using mixed-mode chromatography are more susceptible to sig-
nal enhancement. The observed enhancement of signal response (for example, triiodothyronine and thyroxine 
in Scherzo analysis (Supplementary Figure 2) may be explained by: (i) true matrix effect; (ii) the presence of 
co-eluting isobaric contaminants whose signals were mistakenly included due to insufficient resolution of QTOF; 
(iii) formation of significant amount of adducts in buffer but not in matrix calibration points and/or (iv) limited 
solubility of standard analytes in buffer calibration samples versus plasma extracts. To evaluate possibility (ii), the 
matrix effect experiment was repeated for + ESI Scherzo LC analysis using Orbitrap VelosTM mass spectrometer 
with mass resolution of 100,000. The same enhancement results were observed, so we can conclude that the cause 
of observed ion enhancement is not co-elution of species with similar m/z to the analytes of interest. Next, Na+ 
and NH4+ adduct formation was compared for buffer samples versus plasma extract samples. No significant dif-
ferences in adduct formation were found for any analytes except for melatonin where sodiated adduct with the 
intensity similar to protonated ions was formed in buffer calibration points. To correct for sodiated adduct for-
mation, total area of sodiated and protonated ions was used in calculations of matrix effect for melatonin. Finally, 
the observation of large differences between matrix effects in Scherzo and RP despite identical sample prepara-
tion protocols between these two methods exclude the involvement of partial solubility. Thus, it is plausible to 
conclude that the enhancement effect observed in mixed-mode LC analysis (and occasionally in RP analysis) is 
based on true difference in ionization process between plasma-based and buffer-based samples. This is further 
supported by the fact that for both analytes that exhibit ion enhancement, their isotopically labelled standards 
also confirm the same extent of enhancement showing high quality of the collected data.
Selection of internal standards for global metabolomics. Our recovery and matrix effects results 
can be used to guide the selection of the best internal standards for quality control for human plasma metabolo-
mics. Standards that show no susceptibility to matrix effects make ideal internal standards (as SIL analogues) to 
spike before extraction in order to monitor extraction recovery. These include 5-methoxytryptamine, folic acid, 
thyrothropin releasing hormone and cortisol for + ESI RP; and pantothenic and cholic acids for − ESI RP all of 
which showed no matrix effects across all seven extraction methods tested as shown in Supplementary Table 6. 
These can be supplemented with additional standards spiked post extraction to monitor for matrix effects such 
as SIL analogues of adenine and thyroxine for ± ESI RP; neurotensin, melatonin, thyroxine and cortisol for + ESI 
Scherzo and homovanillic acid, melatonin and thyroxine -ESI Scherzo. These analytes show large differences in 
matrix effects between different extraction methods as shown in Supplementary Figure 2 which suggests their 
ionization is susceptible to presence of possible co-eluting interferences, and do not overlap with proposed recov-
ery standards. The use of matrix effect standards is suggested to evaluate relative matrix effects between individual 
samples but it should be noted that they would only reflect the extent of ion suppression at that specific moment 
of chromatographic run. Finally, the above internal standard suggestions are valid for the exact extraction meth-
ods, plasma loading and LC methods tested in this study. Further testing is required to extrapolate the use of these 
specific standards to other experimental conditions. In general, for any combination of extraction method and 
LC-MS analysis, standards with high recovery in that extraction method and no matrix effects across all extrac-
tions for the chosen LC-MS method would make ideal recovery standards, while standards highly susceptible 
to ion suppression/enhancement would make useful internal standards for monitoring of matrix effects across 
individual samples.
Global Metabolite Analysis
Seven extraction protocols were compared using four LC-MS analyses in order to assess metabolite coverage, 
extraction repeatability and method overlap (orthogonality) as shown in Fig. 2. Table 2 summarizes metabo-
lite coverage and extraction repeatability of all extraction methods tested. As expected, the highest number of 
putative metabolites was extracted by methanol-based solvent precipitation methods, with the highest number 
of putative metabolites (3804) detected for methanol/ethanol. The analysis of organic MTBE fraction resulted 
in 2887 putative metabolites as revealed by + ESI RP analysis. Approximately 30% less metabolite features were 
detected in C18 and PEP2 SPE extracts while only 1835 putative metabolites were observed for IEX SPE. The 
table also shows median RSD of signals across all extraction methods for each LC-MS analysis. Methanol-ethanol 
and methanol extractions demonstrated the best repeatability versus all other extraction methods independently 
of LC-MS method employed. PEP2 and IEX had acceptable repeatability for global metabolomics. On the other 
hand, MTBE and C18 extraction methods demonstrated the worst repeatability independent of LC-MS analysis 
(Table 2). The high proportion of irreproducible features in these two methods requires the application of rigor-
ous quality controls and in-depth investigation for the sources of such irreproducibility. Previous C18 SPE studies 
for plasma metabolomics indicate conflicting evidence regarding C18 repeatability for this application. In the 
first study on this topic, Michopoulos et al. showed 48% and 55% of features detected in C18 SPE and methanol 
precipitation had RSD ≤ 30% respectively, which implied both methods have similar repeatability15. Rico et al. 
also observed similar repeatability between methanol and C18 SPE with approximately 80% of features which 
met 30% RSD criteria for both methods11. Our results show that only 42% of features extracted by C18 SPE met 
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Extraction method










Methanol-ethanol 3804 12.8 3306 1093 13.4 1051 1702 22.3 1087 1278 18.7 930
Methanol-MTBE 3394 17.7 2389 1055 12.7 849 1510 25.2 877 1363 21 897
Methanol 3795 11.5 3483 1035 11.4 940 1538 19 1089 1113 17.9 802
IEX 1835 17.5 1406 415 12.5 364 894 23.2 571 561 23.1 373
MTBE 2887 37.9 1037 618 26.9 362 948 39.1 326 753 31.7 345
PEP2 2430 21 1635 557 14.5 444 1093 24.9 651 773 21.5 498
C18 2459 34.6 1032 603 22.7 394 1078 41.4 318 820 33.2 357
Total metabolome 
coverage 5853 1466 3072 2229
Table 2.  Metabolite coverage and repeatability of extraction methods assessed by global metabolomics 
analysis. This table shows total number of putative metabolites (M) detected in minimum 5 out of 6 extraction 
replicates analyzed using RP or Scherzo mixed-mode LC-MS after removal of features present in blank extracts, 
median RSD of signal intensity across all putative metabolite features detected in the extraction method and the 
number of metabolites for which extraction method was highly repeatable with RSD ≤ 30% for n = 6 independent 
extractions (M30). RSD for each putative metabolite feature was calculated using raw signal intensities in 
extraction replicates (n = 6). Number of features with RSD ≤ 30% (between replicates) represent high quality 
features that could be used for biomarker discovery and pathway analysis in global metabolomics projects.
Figure 3. Hierarchical clustering of the number of putative metabolites detected in plasma extracts and 
pairwise overlap coverage of seven extraction methods. Samples were analyzed using + ESI RP (a) − ESI 
RP (b), + ESI Scherzo (c) and − ESI Scherzo (d). Red colour boxes located across the diagonal show the total 
number of putative metabolites detected with that extraction method from plasma. Yellow, white and cyan 
blue colors designate high (99.9–80% overlap), medium (79.9–50.0%) and low (50.0–0% overlap) of putative 
metabolite populations observed by the two extraction methods specified. Therefore, the methods indicated 
with cyan blue boxes are the most orthogonal pairs of methods across all of the seven extraction methods tested.
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the repeatability criteria which is consistent with Michopoulos et al. study15. However, our results also show vast 
superiority of methanol repeatability where 92% of features were highly repeatable with RSD ≤ 30% for n = 6 
extraction replicates. Considering this discrepancy across the studies for C18 SPE, further investigation of the fac-
tors affecting repeatability is required. Such contributing factors may include lack of automation used in our study 
and the exact selection of sorbent characteristics and wash/elution conditions. For instance, our study employed 
acetonitrile, whereas both Michopoulos et al. and Rico et al. used methanol as elution solvent which may have 
contributed to the poor precision11,15. Our MTBE results are in contrast to good precision obtained when using 
MTBE with in-vial dual extraction method where ≥ 80% of features had RSD ≤ 30% for n = 3 extraction repli-
cates14. The same authors observed poor precision of MTBE LLE with evaporation/reconstitution step whereby 
only 56% of detected features exhibited RSD ≤  30%. The latter result is consistent with the results of the current 
study where evaporation/reconstitution step was employed. During their evaluation of optimum method for lipi-
domics, Sarafian et al. also showed poor repeatability of MTBE in comparison to methanol with a similar 2-fold 
deterioration of mean RSD and the numbers of highly reproducible lipids32 consistent with what was observed in 
current study. During further investigation of MTBE extraction repeatability, the repeatability of solvent pipetting 
was investigated and found not to be significant contributing factor to overall method performance. Next, the 
+ ESI RP LC-MS analysis of newly-prepared aqueous and organic layers obtained after MTBE extraction found 
that aqueous extracts had repeatability similar to that of methanol (median RSD of 15.7% for MTBE aqueous) 
versus 16.0% RSD for methanol obtained during this follow-up experiment. In contrast, organic extracts had 
median RSD of 36.4% which is consistent with 37.9% median RSD obtained in our initial experiment presented 
in Table 2. Detailed investigation of this data showed clear dependence of RSD on retention time: large propor-
tion of peaks eluting with retention time of > 20 min had RSDs greater than 50% in both methanol and MTBE 
extracts. Methanol had large number of peaks with retention time < 20 min which exhibited good repeatability, 
which resulted in good median RSDs observed for the global metabolomics data. MTBE, on the other hand, had 
only small number of metabolites eluting with retention time < 20 min, and very high proportion of metabolites 
with retention time > 20 min, which resulted in overall higher median RSDs observed in Table 2. Based on this 
evidence, it is believed that poor MTBE repeatability observed in our study may not arise from the extraction 
method itself, but from poor match between the composition of MTBE extract and RP and mixed-mode LC sepa-
ration methods employed in this study which would not adequately separate lipids extracted by MTBE. This con-
clusion is further supported by the observed increase in median RSD from 35.4 to 50.9% when one-step MTBE 
and two-step MTBE extractions were compared. Although 2-step extraction increased recovery of few mid-polar 
metabolites, this also increased the extent of co-elution thus causing further deterioration in RSD.
Further analysis of Table 2 across LC-MS methods demonstrated inferior reproducibility of Scherzo analysis 
comparative to RP. This is attributed to lower resolution of Scherzo column (larger particle size than RP column) 
and larger matrix effect than in RP as shown in Matrix Effects section. Finally, hierarchical analysis was per-
formed to determine pairwise orthogonality of each of the methods tested. The results are shown in Fig. 3. The 
hierarchical clustering confirms the high orthogonality of IEX and MTBE to other methods observed in targeted 
Figure 4. PCA analysis of seven extraction methods and quality control samples analyzed on four LC-MS 
methods (a,b – reversed phase analysis; c,d – Scherzo mixed-mode analysis in positive and negative ESI, 
respectively) executed on all metabolites that satisfy criteria described in main text (not present in blank, and 
present in minimum of 5 out of 6 replicates of at least one extraction method). The graph displays colored 
spheres for blank (red), QC (dark grey), IEX (dark gold), C18 (yellow), PEP2 (blue), MTBE (black), methanol-
MTBE (violet), methanol-ethanol (green) extraction replicates and red diamonds for methanol extraction 
replicates. The plots show the top two principal components. Numbering of replicates corresponds to their 
sequential injection order in a given LC-MS analysis. Analysis was executed using multivariate analysis software 
SIMCA (v 14.1.64, Umetrics, San Jose, CA, USA) after Pareto scaling.
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analysis, similarity between methanol-based extractions and similarity between C18 and PEP2 SPE methods. 
Our orthogonality results for methanol and C18 SPE (1825/2459 putative metabolites =74% overlap using data 
shown in Fig. 3) are consistent with what was reported by Rico et al. who observed 58–68% overlap between the 
two methods and ability to detect 600 additional features when comparing SPE to methanol precipitation10. Using 
+ ESI RP analysis, total of 5853 non-redundant putative metabolite features were detected across all seven extrac-
tion methods tested. This represents only 54% improvement over the single best extraction method of methanol/
ethanol (3804 putative metabolites) or methanol (3795 putative metabolites). Therefore, 7x increase in MS anal-
ysis time and the use of LLE and SPE with widely different selectivity mechanisms did not provide a huge boost 
in our ability to detect low abundance metabolome. Similar results were observed for other LC-MS methods 
where the increases were 34% (− ESI RP LC-MS), 80% (+ ESI mixed mode LC-MS) and 74% (− ESI mixed mode 
LC-MS). These results clearly show that simply using multiple extraction methods in parallel is not the best way 
to increase metabolite coverage and that sequential extractions should be explored to further boost metabolome 
coverage. Figure 4 shows principal component analysis results for all extraction and LC-MS methods further 
illustrating that IEX and MTBE are the most complementary methods to methanol-based solvent precipitation.
Conclusions
For the first time, absolute analyte recoveries and matrix effects in plasma were systematically assessed for seven 
solvent precipitations, LLE and SPE methods using standard addition calibration. In addition, method repeat-
ability, orthogonality and metabolome coverage were compared in combination with two reversed-phased and 
mixed-mode LC-MS methods. Our results confirm wide selectivity of methanol-based precipitation methods 
versus LLE and SPE, with the best results observed using methanol or methanol/ethanol as shown in Table 3. 
However, methanol-based methods suffer from severe matrix effects which negatively impacts data quality and 
may result in inaccurate selection of tentative biomarkers. We also show that IEX and PEP2 SPE provide accept-
able performance for global metabolomics studies of plasma, and can be employed depending on the desired cov-
erage of the metabolome for a given application. Our analysis platform revealed high orthogonality of MTBE and 
IEX to each other and other methods, providing the possibility of increased metabolome coverage via sequential 
application of these methods.
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